The U.S. Supreme Court issued its long-awaited decision in Association of Molecular Pathology v. Myriad Genetics, Inc. on the patent eligibility of DNA molecules. On the surface, the ruling may appear clear cut, but is it? And what will be the effects of the ruling?

To help Attendees hear the patient’s voice more clearly and understand the patient perspective, we are pleased to present two film documentaries, brought to you by The Kauffman Foundation, on Tuesday and Wednesday evening. Wednesday’s documentary is Here.Us.Now.

Top executives from the regulatory agencies in Canada, the European Union, and the United States addressed an overflow crowd in a lively question and answer session on Cooperation Among Regulators: Impact on Stakeholders held Monday afternoon.

DIA’s Patient Advocate Fellowship Program supports the Annual Meeting participation of patient advocacy and patient group representatives, which provides opportunities for them to strengthen and support their collaborations with policy makers, health care professionals, industry representatives and other important groups. Twenty Advocates were selected to participate in this year’s program.